Suboptimal Clinician Awareness of Appropriate NTRK Fusion Testing and TRK Inhibitor Use in Solid Tumors

This poster, presented at the 2021 ASCO Quality Care Symposium, features an analysis of data from 12 CME-certified programs and demonstrates an ongoing need for healthcare professional education focused on NTRK fusion testing and optimal use of TRK inhibitor therapies in patients with solid tumors.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings